Baxter Bros Inc’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$274K Hold
3,165
0.03% 145
2025
Q4
$304K Sell
3,165
-160
-5% -$15.5K 0.04% 140
2025
Q3
$317K Sell
3,325
-65
-2% -$5.97K 0.04% 138
2025
Q2
$296K Sell
3,390
-1,440
-30% -$122K 0.04% 131
2025
Q1
$434K Sell
4,830
-20
-0.4% -$1.79K 0.06% 114
2024
Q4
$387K Sell
4,850
-850
-15% -$73.6K 0.05% 117
2024
Q3
$513K Sell
5,700
-814
-12% -$68.5K 0.07% 106
2024
Q2
$513K Sell
6,514
-600
-8% -$49.2K 0.07% 107
2024
Q1
$620K Sell
7,114
-425
-6% -$36.3K 0.08% 99
2023
Q4
$621K Sell
7,539
-75
-1% -$5.72K 0.09% 94
2023
Q3
$597K Sell
7,614
-300
-4% -$25.1K 0.09% 94
2023
Q2
$697K Sell
7,914
-200
-2% -$17.2K 0.1% 83
2023
Q1
$654K Sell
8,114
-190
-2% -$15.5K 0.1% 85
2022
Q4
$645K Sell
8,304
-820
-9% -$66.5K 0.11% 83
2022
Q3
$737K Buy
9,124
+800
+10% +$71.9K 0.13% 80
2022
Q2
$747K Hold
8,324
0.13% 75
2022
Q1
$924K Buy
8,324
+500
+6% +$52.8K 0.14% 75
2021
Q4
$809K Sell
7,824
-400
-5% -$46.3K 0.12% 76
2021
Q3
$1.03M Sell
8,224
-371
-4% -$48K 0.17% 71
2021
Q2
$1.07M Buy
8,595
+176
+2% +$22.1K 0.17% 69
2021
Q1
$995K Sell
8,419
-150
-2% -$17.6K 0.17% 67
2020
Q4
$1M Buy
8,569
+100
+1% +$11K 0.19% 67
2020
Q3
$880K Sell
8,469
-200
-2% -$20.1K 0.19% 66
2020
Q2
$795K Sell
8,669
-125
-1% -$12K 0.19% 68
2020
Q1
$793K Hold
8,794
0.21% 69
2019
Q4
$998K Sell
8,794
-50
-0.6% -$5.49K 0.21% 68
2019
Q3
$961K Hold
8,844
0.22% 64
2019
Q2
$861K Sell
8,844
-150
-2% -$13.7K 0.2% 68
2019
Q1
$819K Sell
8,994
-800
-8% -$71.6K 0.19% 70
2018
Q4
$891K Sell
9,794
-300
-3% -$28K 0.24% 64
2018
Q3
$993K Hold
10,094
0.24% 65
2018
Q2
$864K Hold
10,094
0.23% 68
2018
Q1
$810K Sell
10,094
-100
-1% -$8.25K 0.22% 72
2017
Q4
$823K Sell
10,194
-280
-3% -$22.4K 0.23% 68
2017
Q3
$815K Sell
10,474
-50
-0.5% -$4.15K 0.23% 69
2017
Q2
$934K Hold
10,524
0.28% 64
2017
Q1
$848K Sell
10,524
-875
-8% -$68.3K 0.27% 62
2016
Q4
$812K Sell
11,399
-2,100
-16% -$165K 0.26% 62
2016
Q3
$1.17M Sell
13,499
-1,860
-12% -$162K 0.39% 50
2016
Q2
$1.33M Buy
+15,359
New +$1.24M 0.47% 48
2015
Q4
$1.18M Sell
15,324
-1,288
-8% -$97K 0.44% 53
2015
Q3
$1.23M Hold
16,612
0.45% 52
2015
Q2
$1.23M Hold
16,612
0.45% 52
2015
Q1
$1.3M Hold
16,612
0.47% 52
2014
Q4
$1.2M Sell
16,612
-100
-0.6% -$6.95K 0.43% 50
2014
Q3
$1.03M Sell
16,712
-233
-1% -$14.8K 0.4% 52
2014
Q2
$1.08M Sell
16,945
-250
-1% -$15.2K 0.44% 52
2014
Q1
$1.06M Sell
17,195
-150
-0.9% -$8.74K 0.48% 49
2013
Q4
$995K Sell
17,345
-3,040
-15% -$172K 0.47% 49
2013
Q3
$1.09M Sell
20,385
-500
-2% -$26.9K 0.59% 46
2013
Q2
$1.07M Buy
+20,885
New +$1.03M 0.65% 40

Other funds holding MDT

Baxter Bros Inc's MDT Position: Q1 2026 in Review

Baxter Bros Inc held its Medtronic (MDT) position steady in Q1 2026 at 3,165 shares worth $274K. The position accounts for 0.03% of the portfolio, ranked #145.

Baxter Bros Inc first reported a position in MDT in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.33M in Q2 2016. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Baxter Bros Inc held 3,165 shares of Medtronic worth $274K as of Q1 2026.
  • Baxter Bros Inc left its Medtronic share count unchanged in Q1 2026.
  • Medtronic made up 0.03% of Baxter Bros Inc's portfolio in Q1 2026, its #145 holding.
  • Baxter Bros Inc first reported a position in Medtronic in Q2 2013 and has held it in 51 quarters since.
  • Baxter Bros Inc's Medtronic position peaked at $1.33M in Q2 2016.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Baxter Bros Inc's 13F filing for Q1 2026, filed 28 Apr 2026.